Real-time enrollment status for this chronic kidney disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 8:20 PM UTC
| NCT Number | NCT07024823 |
| Recruiting Status | Recruiting |
| Condition | Chronic Kidney Disease |
| Phase | PHASE1 |
| Target Enrollment | 124 participants |
| Active Locations | 5 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 1, 2026 (2 weeks ago) |
As of July 19, 2026: Clinical trial NCT07024823 is currently recruiting participants. This phase1 study for chronic kidney disease is actively seeking new participants at 5 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07024823 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07024823 was last updated 2 weeks ago (July 1, 2026). HelloStudys verifies this status automatically.